Atopic Dermatitis (AD) Treatment Initiation and Monitoring
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA …
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA … Continue reading "Atopic Dermatitis (AD) Treatment Initiation and Monitoring"
On this Mnemonic Monday, we challenge you to remember metabolic syndromes associated with trichorrhexis nodosa (TN) of the hair with the following mnemonic:
BLT Noodles
B=Brooms, (e.g. frayed hair fibers with the appearance of two broomsticks pushed together in trichorrhexis nodosa)
L=Low= helps remind you that this is associated with metabolic syndromes, with varying low or high leve … 
On this Mnemonic Monday, we challenge you to remember the side effects of hedgehog inhibitors, vismodegib and sonidegib, with the following mnemonic:
MAD Weight loss
M=muscle spasm (72% of cases)
A=alopecia (64% of cases)
D= dysgeusia (55% of cases)
Weight loss= weight loss (45% of cases)
Click HERE to download or print your mnemonic card.
Study More!
Need a refresher on he … 
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Various forms of alopecia affect millions of individuals worldwide and its prevalence appears to be increasing.1 Hair loss often leads to significant distress and negatively impacts quality of life. Treatment often requires a multimodal approach, and patient satisfaction is highly variable. Dermatologists have limited tools in their treatment armamentarium and may often resort to off-label use of … 